ArticleThoracic cancer2021

Hexokinases II-mediated glycolysis governs susceptibility to crizotinib in ALK-positive non-small cell lung cancer.

Caiyu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.